Gene Query: ZCCHC7

Dataset Description Geneva Score
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 55.79
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 34.93
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 34.46
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 24.93
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 23.62
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 19.1
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 19.1
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 18.53
Gene expression analysis of dengue-infected cells 15.1
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 13.94
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 13.56
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 12.83
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 12.82
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 12.82
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 11.97
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 11.75
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 10.5
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 10.19
LncRNA expression profiling of ischemic stroke patients 10.03
MYC dependent mRNA translation shapes gene expression and cell biology 10.03
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 9.7
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 9.59
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 9.59
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 9.53
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 9.49
The evolution of N6-methyladenosine in primates 9.35
CircRNAome diversity in human mature B-cells, T-cells and monocytes 9.32
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 9.22
MYCi975 regulates MYC target genes 9.0
RNA sequencing of human mammary epithelial cells 8.98
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 8.84
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 8.84
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 8.78
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 8.71
Global Mapping of Human RNA-RNA Interactions 8.59
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 8.53
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 8.46
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 8.33
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 8.23
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 7.95
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 7.87
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 7.74
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 7.57
BACH2 in human plasma cell fate decision 7.23
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 7.17
Genetic-to-epigenetic Therapy for Pancreatic Cancer 7.03
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 6.84
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 6.81
Transcriptional profiles of normal human mature B cells 6.75
Be1 and Be2 B cells are transcriptionally distinct 6.74
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 6.62
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.51
Non-coding regions are the main source of tumor-specific antigens 6.38
Non-coding regions are the main source of tumor-specific antigens [human] 6.38
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 6.2
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 6.2
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 6.18
RNA polymerase in pre-B-ALL cell lines 6.16
TT-Seq captures the human transient transcriptome 6.15
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 6.12
RNA sequencing with KSHV infection and enrichment for circular RNAs 6.01
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 5.93
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 5.83
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 5.79
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 5.64
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 5.62
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.61
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 5.56
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 5.54
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.52
MYCi361 regulates MYC target genes 5.41
Transcriptional profile in human S. haematobium infection 5.32
Integrating single-cell transcriptomic data across different conditions, technologies, and species 5.32
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 5.31
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 5.23
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 5.23
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 5.21
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 5.13
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.1
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 5.1
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 5.1
U2AF1 mutations alter splice site recognition in hematological malignancies 5.04
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.02
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.0
Targeting MTHFD2 in Acute Myeloid Leukemia 4.97
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 4.95
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 4.94
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.83
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.83
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 4.8
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 4.79
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 4.79
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 4.72
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 4.72
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 4.7
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 4.67
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 4.67
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 4.64
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.62
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 4.61
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 4.57
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 4.57
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 4.55
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 4.54
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 4.53
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 4.51
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.5
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 4.44
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 4.4
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.4
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 4.39
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 4.39
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.3
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 4.26
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 4.21
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 4.2
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 4.2
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 4.17
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 4.16
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 4.14
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 4.1
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 4.1
SLAM-seq for K562 endogenous mRNA decay 4.09
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 4.08
AUF-1 affected genes in human skin cells 4.05
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 4.03
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 4.03
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.01
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 3.99
Seletive inhibition of CDK9 in DLBCL cell lines 3.99
Accurate annotation of human protein-coding small open reading frames 3.97
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.95
Genome-wide discovery of human splicing branchpoints 3.9
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 3.82
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.81
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 3.79
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 3.79
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 3.77
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 3.77
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 3.75
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.74
Integrin signaling regulates YAP/TAZ to control skin homeostasis 3.71
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 3.69
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 3.67
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 3.64
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.63
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 3.61
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 3.6
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.59
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 3.57
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 3.57
MeRIP-seq for heat shock in B-cell lymphoma cells 3.56
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 3.55
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 3.52
Tracking of dCas9-methyltransferase footprints 3.52
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.51
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 3.49
Genome-wide analysis of the Integrator complex (HTS) 3.48
Genome-wide analysis of the Integrator complex 3.48
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.47
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 3.47
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 3.46
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.45
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 3.45
Neonatal and adult human testis defined at the single-cell level 3.45
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.45
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 3.45
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 3.43
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 3.43
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 3.42
Capturing the Interactome of Newly Transcribed RNA 3.4
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.4
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.37
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 3.36
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 3.36
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 3.36
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 3.36
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 3.35
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.35
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 3.33
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.27
Short and Long RNA sequencing of human mature erythrocytes 3.24
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 3.24
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.22
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 3.22
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 3.21
Landscape of H3K4me3 in human CD19 cells 3.19
Expression level comparison under dividing and quiescent states in human primary fibroblasts 3.19
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 3.18
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.14
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.13
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 3.11
RNA expression analysis upon JMJD1C depletion 3.11
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 3.08
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 3.07
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.04
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 3.03
Ro60-knockout cells 3.03
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 3.03
SLIGRL-induced gene expression changes in NHEK cells 3.02
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 3.01
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 3.01
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.01
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.01
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.01
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 2.99
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 2.98
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.97
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 2.96
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.95
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 2.94
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 2.93
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.92
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 2.91
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 2.9
RNA-seq of resting and activated CD4+ T cells +-JQ1 2.9
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 2.9
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 2.89
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 2.89
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.88
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.88
Endothelial gene expression analysis 2.87
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 2.87
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 2.87
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.85
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.85
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 2.82
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.81
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.81
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 2.81
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.8
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.79
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 2.79
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.77
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.77
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 2.77
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 2.75
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 2.75
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.75
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 2.75
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 2.75
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.74
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.72
Gene expression changes due to PARP knockdown in human cells 2.72
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.68
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.68
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 2.67
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 2.66
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 2.63
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 2.6
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.6
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 2.59
IRF1 regulates IFN dependent and independent gene expression 2.57
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 2.57
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.57
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 2.56
Loss of CREBBP results in gene expression repression in lymphoma cells 2.55
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.55
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 2.53
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 2.51
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.51
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.5
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.49
Transcriptome analysis of CNS leukemia 2.48
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.48
Bone marrow derived human B cells [normal proB] 2.44
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 2.44
RNA-seq analysis of control and Myc-induced U2OS cells 2.44
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.43
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 2.43
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.41
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.4
Regulation of protein translation during mitosis 2.4
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 2.4
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.38
RNA-sequencing of formalin fixed human primary melanoma tissue 2.38
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.37
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.37
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.35
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.35
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.33
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.33
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.33
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.33
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.32
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 2.31
Illumina Total RNA-seq in HeLa 2.31
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.3
Regulation of hypoxia-inducible factor activity by ZMYND8 2.3
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.28
Gene expression signatures of innate lymphoid cells from human blood 2.28
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 2.27
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 2.27
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.26
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 2.24
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 2.24
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 2.21
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.19
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.17
Generation of KRAS signatures using immortalized isogenic lung cells. 2.16
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.14
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.14
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.14
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.13
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.13
Spliceosomal disruption of the non-canonical BAF complex in cancer 2.09
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 2.08
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.08
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 2.07
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.07
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 2.05
Global analysis of enhancer targets: Mosaic-seq 2.04
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.03
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 2.0
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 2.0
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 1.99
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.93
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.93
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.93
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.91
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 1.89
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.88
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.87
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.82
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.82
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.8
K562 polyA RNA-Seq 1.8
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.79
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 1.76
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 1.75
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.74
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.72
Widespread intronic polyadenylation diversifies immune cell transcriptomes 1.72
Effect of drugs on transcriptomic profiles 1.71
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.7
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 1.69
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 1.69
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.66
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 1.66
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.66
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.66
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.63
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.63
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.62
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.62
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.57
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.55
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 1.54
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.52
Transcriptomes in healthy and CHB fetal hearts 1.5
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.49
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.49
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.47
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.45
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.45
Identification of long noncoding RNAs in T-ALL cell lines 1.45
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.43
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.41
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.39
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.39
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.38
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.38
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 1.37
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 1.37
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 1.37
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 1.37
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 1.37
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.36
Functional significance of the HIV-1 Tat signature amino acid residues 1.35
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.33
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.33
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.33
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.29
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 1.27
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 1.27
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.25
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.25
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.25
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 1.21
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.21
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.21
N6-methyladenine DNA Modification in Glioblastoma 1.21
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.17
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.17
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 1.17
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 1.17
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 1.13
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.12
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.12
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.12
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.11
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 1.11
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.09
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.09
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.09
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.07
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 1.05
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.04
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.02
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.02
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.01
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.01
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.01
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.99
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.99
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.99
Total RNA-Seq data from leukemic patients with complex structural variants 0.99
SNHG5 siRNA knock down in HCT116 cells 0.97
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.96
Aging-associated patterns in the expression of human endogenous retroviruses 0.95
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.94
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.91
Human Treg IFNg/IL-10 subpopulations 0.91
RNA-seq data 0.91
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.9
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.9
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.85
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.84
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.83
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 0.77
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.76
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.76
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 0.76
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.76
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.73
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.73
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.73
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.72
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.72
mRNA expression profile of Lymphocytes 0.72
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.72
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.71
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.71
Gene expression alterations of pancreatic intraepithlial neoplasia 0.7
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.69
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.69
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.66
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.66
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.66
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.66
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.65
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.65
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.64
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.64
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.63
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.6
CD74 role in transcription regulation [RNA-seq] 0.6
CD74 role in transcription regulation 0.6
MARCKS and lnc-MARCKS act as inflammation regulators 0.59
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.58
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.57
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.56
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.49
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.46
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 0.46
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 0.44
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.44
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.44
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.4
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.38
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.38
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.38
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.38
In vitro modeling of human germ cell development using pluripotent stem cells 0.38
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.33
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.33
RNAseq analysis of ruxolitinib treated breast cancers 0.32
IMP3 regulated gene expression in breast cancer cells 0.32
Gene expression activation in CLL mediated by MSCs contact 0.32
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.32
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.32
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.29
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.28
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.26
Transcriptional landscape changes during human embryonic stem cell derivation 0.25
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.23
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.22
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.2
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.18
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.18
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.18
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.17
Identification of a LIF-responsive replication-competent human β cell 0.17
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.16
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.16
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.11
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.1
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.09
MicroRNA-125a-5p overexpression in human macrophages 0.08
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.08
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.07
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.07
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.07
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.05
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.05
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 0.05
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.04
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.02
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation